WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line

The Wilms' tumour suppressor WT1 (Wilms' tumour 1) is a transcriptional regulator that plays a central role in organogenesis, and is mutated or aberrantly expressed in several childhood and adult malignancies. We previously identified BASP1 (brain acid-soluble protein 1) as a WT1 cofactor that suppresses the transcriptional activation function of WT1. In the present study we have analysed the dynamic between WT1 and BASP1 in the regulation of gene expression in myelogenous leukaemia K562 cells. Our findings reveal that BASP1 is a significant regulator of WT1 that is recruited to WT1-binding sites and suppresses WT1-mediated transcriptional activation at several WT1 target genes. We find that WT1 and BASP1 can divert the differentiation programme of K562 cells to a non-blood cell type following induction by the phorbol ester PMA. WT1 and BASP1 co-operate to induce the differentiation of K562 cells to a neuronal-like morphology that exhibits extensive arborization, and the expression of several genes involved in neurite outgrowth and synapse formation. Functional analysis revealed the relevance of the transcriptional reprogramming and morphological changes, in that the cells elicited a response to the neurotransmitter ATP. Taken together, the results of the present study reveal that WT1 and BASP1 can divert the lineage potential of an established blood cell line towards a cell with neuronal characteristics.

[1]  S. Ariyaratana,et al.  The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis , 2007, Expert Reviews in Molecular Medicine.

[2]  Jia Yu,et al.  Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation , 2006, Molecular and Cellular Biochemistry.

[3]  Matthias Mann,et al.  BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1 , 2004, Molecular and Cellular Biology.

[4]  K. Wagner,et al.  The Wilms' tumor gene Wt1 is required for normal development of the retina , 2002, The EMBO journal.

[5]  F. Benfenati,et al.  The role of synapsins in neuronal development , 2010, Cellular and Molecular Life Sciences.

[6]  M. Hartl,et al.  Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1) , 2009, Proceedings of the National Academy of Sciences.

[7]  G. Bokoch,et al.  Membrane targeting of p21‐activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells , 1998, The EMBO journal.

[8]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[9]  J. Hartkamp,et al.  The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi , 2010, Molecular cell.

[10]  J. Sanes,et al.  A synaptic nidogen: Developmental regulation and role of nidogen-2 at the neuromuscular junction , 2008, Neural Development.

[11]  U. Scherf,et al.  Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL1 , 2003, The Journal of Immunology.

[12]  K. Coombes,et al.  Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors , 2003, Oncogene.

[13]  K. Wagner,et al.  The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo , 2008, Oncogene.

[14]  M. Rivera,et al.  Wilms' tumour: connecting tumorigenesis and organ development in the kidney , 2005, Nature Reviews Cancer.

[15]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[16]  H. Avraham,et al.  NRP/B, a Novel Nuclear Matrix Protein, Associates With p110RB and Is Involved in Neuronal Differentiation , 1998, The Journal of cell biology.

[17]  B. Hagberg,et al.  The Nosology of Genetic Peripheral Neuropathies in Swedish Children , 1983, Developmental medicine and child neurology.

[18]  J. Pelletier,et al.  Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter. , 2001, Physiological genomics.

[19]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[20]  S. Roberts.  Transcriptional regulation by WT1 in development. , 2005, Current opinion in genetics & development.

[21]  P. Caroni,et al.  Characterization of BASP1‐mediated neurite outgrowth , 2008, Journal of neuroscience research.

[22]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[23]  K. Wagner,et al.  A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system , 2005, Development.

[24]  C. Mervis,et al.  Rearrangements of the Williams–Beuren syndrome locus: molecular basis and implications for speech and language development , 2007, Expert Reviews in Molecular Medicine.

[25]  Jared M Flatow,et al.  An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 , 2009, Proceedings of the National Academy of Sciences.

[26]  A. Gaiger,et al.  WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies , 2003, Leukemia.

[27]  Ioannis S Vizirianakis,et al.  Mechanisms involved in the induced differentiation of leukemia cells. , 2003, Pharmacology & therapeutics.

[28]  Stefan G. E. Roberts,et al.  Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation , 2008, Nucleic acids research.

[29]  B. Carpenter,et al.  Regulation of the Wilms' tumour suppressor protein transcriptional activation domain , 1999, Oncogene.

[30]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Bomsztyk,et al.  Protocol for the fast chromatin immunoprecipitation (ChIP) method , 2006, Nature Protocols.

[32]  W. Gerald,et al.  The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.

[33]  Peter Hohenstein,et al.  The many facets of the Wilms' tumour gene, WT1. , 2006, Human molecular genetics.

[34]  Kevin R. Coombes,et al.  Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies , 2004, Bioinform..

[35]  M. Cam,et al.  Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development* , 2007, Journal of Biological Chemistry.

[36]  R. North.  Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[37]  K. Wagner,et al.  The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[39]  J. Bard,et al.  The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo , 1993, Mechanisms of Development.

[40]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Tulio de Oliveira,et al.  The RNA Virus Database , 2008, Nucleic Acids Res..

[42]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[43]  A. Patzak,et al.  Wilms' tumor protein (-KTS) modulates renin gene transcription. , 2008, Kidney international.

[44]  Yoshihiko Hamamoto,et al.  Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. , 2008, International journal of oncology.

[45]  Kyoko Saito,et al.  Process formation of the renal glomerular podocyte: Is there common molecular machinery for processes of podocytes and neurons? , 2004, Anatomical science international.

[46]  M. Mosevitsky.  Nerve ending "signal" proteins GAP-43, MARCKS, and BASP1. , 2005, International review of cytology.

[47]  T. Katada,et al.  Novel antibody to human BASP1 labels apoptotic cells post-caspase activation. , 2008, Biochemical and biophysical research communications.